Low Coenzyme Q10 in Hereditary Hemochromatosis

In a 2021 study, patients with hereditary hemochromatosis were observed to have significantly lower plasma concentrations of Coenzyme Q10 [Martinefski 2021].

Jan Aaseth
Professor Jan Aaseth has published medical journal articles about the treatment options for iron overload: phlebotomy and chelation. Phlebotomy is the initial treatment of choice in hemochromatosis.

Hereditary hemochromatosis is a genetic disorder that causes the body to build up too much iron in various organs including the heart and liver. The iron overload is toxic and can damage tissues and organs and lead to liver disease [CDC 2020].

The CDC reports that one-third of one percent of non-Hispanic Caucasians in the US has hereditary hemochromatosis. The rates are somewhat lower in other races and ethnic groups. It is more common for men to develop complications, often at an earlier age. Approximately one in ten men with hereditary hemochromatosis will develop severe liver disease.

read more